While investigations of the latter gene suggest that it plays a role in susceptibility, rather than outcome (9), the HLA–DRB1 gene has been associated with disease severity in IP patients in general and in RA patients in particular (7,10,11). The gene discussed is HLA-DRB1; the disease is rheumatoid arthritis.